Shareholders: Cast Your KraneShares Proxy Vote Today

Latest Content:

KURE

Healthcare ETF: Outbound Biotech Licensing As Potential New Growth Driver In China

KURE

KURE: Capitalizing on China’s Healthcare Revolution

New Drivers For China Healthcare: AI Med-Tech Innovation, Cancer Treatment, & Favorable Balance of Trade

By Henry Greene, Investment Strategist

Outlook Healthier For Key Chinese Sector

By Anthony Sassine, CFA and Henry Greene

China Health Care: A Rediscovered Sector Keeps Its Momentum

China’s Healthcare System Uncovered Online Medicine and Beneficiaries of the COVID-19 Pandemic

KURE: China Healthcare, A Bright Spot in Q1 2020